Conforma Therapeutics Corporation
Records under this name other than patents Conforma Therapeutics Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Conforma Therapeutics Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,093,229 | Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors Term ended Term ended Aug 31, 2026 · USPTO record | Term ended | Term ended Aug 31, 2026 | USPTO record |
| US 7,544,672 | Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors Term ended Term ended Jun 9, 2026 · USPTO record | Term ended | Term ended Jun 9, 2026 | USPTO record |
| US 7,138,402 | Pyrrolopyrimidines and related analogs as HSP90-inhibitors Term ended Term ended Nov 17, 2024 · USPTO record | Term ended | Term ended Nov 17, 2024 | USPTO record |
| US 7,138,401 | 2-aminopurine analogs having HSP90-inhibiting activity Term ended Term ended Oct 13, 2024 · USPTO record | Term ended | Term ended Oct 13, 2024 | USPTO record |
| US 7,129,244 | Triazolopyrimidines and related analogs as HSP90-inhibitors Term ended Term ended Sep 20, 2024 · USPTO record | Term ended | Term ended Sep 20, 2024 | USPTO record |
| US 7,148,228 | Pyrazolopyrimidines and related analogs as HSP90-inhibitors Term ended Term ended Sep 20, 2024 · USPTO record | Term ended | Term ended Sep 20, 2024 | USPTO record |
| US 7,241,890 | Purine analogs having HSP90-inhibiting activity Term ended Term ended Oct 30, 2022 · USPTO record | Term ended | Term ended Oct 30, 2022 | USPTO record |
| US 7,579,462 | Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins Lapsed on the fee record Ended Aug 25, 2013 · USPTO record | Lapsed on the fee record | Ended Aug 25, 2013 | USPTO record |
| US 7,553,979 | HSP90-inhibiting zearalanol compounds and methods of producing and using same Lapsed on the fee record Ended Jun 30, 2013 · USPTO record | Lapsed on the fee record | Ended Jun 30, 2013 | USPTO record |
| US 7,465,718 | Ansamycins having improved pharmacological and biological properties Lapsed on the fee record Ended Dec 16, 2012 · USPTO record | Lapsed on the fee record | Ended Dec 16, 2012 | USPTO record |